Stanozolol USP 10mg
each tablet contains:
Storage: store below 30c in dry place protect from light
for dosage administration and detailed direction for use see package insert
(Stanozolol Injection 50 mg/ml)
Each ml contains:
Stanozolol USP 50 mg
Read this entire leaﬂet carefully before you use this medicine
Indications and usage
Hereditary angioedema : Stromba is indicated prophylactically to decrease the frequency and severity of attacks of angioedema.
The use of Win XW is contraindicated in the following:
- Carcinoma of the prostate of breast in male patients.
- Carcinoma of the breast in some females
- Nephrosis or the nephritic phase of nephritis.
- Stromba can cause fatal harm when administered to a pregnant women
If this drug is used during pregnancy or if the patient becomes pregnant while talking this drug, the patient should be apprised of the potential hazard to the foetus.
Anabolic steroids may increase sensitivity to anticoagulants: therefore, dosage of an anticoagulant may have to be decreased in order to maintain the prothrombin time at the desired therapeutic level.
There have been no reports of acute over dosage with the androgens.
General: women should be observed for signs of virilisation (deepening of the voice, hirsutism, acne, and clitoromegaly). To prevent irreversible change, drug therapy must be discontinued, or the dosage signiﬁcantly reduced. Such virilisation is usual following androgenic anabolic steroid use at high dosages. some virilising changes in women are irreversible even after prompt discontinuance of therapy and are not prevented by concorntant use of estrogens. Menstrual irregularities may also occur. The insulin or oral hypoglycemic dosage may need adjustment in diabetic patients who receive anabolic steroids.
Information for the Patient: The physician should instruct patients to report any of the following side eﬁects of androgens.
Adult or Adolescent Males: Too frequent or persistent erections of the penis, appearance of aggravation of acne.
Women: Hoarseness, acne changes in menstrual periods, or more hair on the face.
All Patients: Any nausea, vomiting, changes in skin colour, or ankle swelling.
Laboratory Test: Women with disseminated breast carcinoma should have frequent determination of urine and serum, calcium levels. Because of the hepatotxicity associated with the use of l7-alpha-alkylated androgens, liver function tests should be obtained periodically. Periodic (every 6 months) X-ray examinations of bone age should be made during treatment of prepubertal patients to determine the rate of bone maturation and the effects of androgenric anabolic steroid, therapy on the epiphyseal centres. In common with other anabolic steroid, Stromba has been reported to lower the level of high-density lipoproteins and raise the level of low-density lipoproteins. These changes usually revert to normal on discontinuation of treatment. Increased low-density lipoproteins and decreased high-density lipoproteins and considered cardiovascular risk factors.
Drug/Laboratory. Therapy with androgenic anabolic steroids may decrease levels of thyroxin binding globulin resulting in decreased totel T4 serum levels and increase resin uptake of T3 and T4, free thyroid hormone levels remain unchanged.
Anabolic steroids may cause an increase in prothrombin time.
Pregnancy Category X.
Nursing Mothers: Stromba is not known whether anabolic steroids are excreted in human milk.
Paediatric use. Anabolic agents may accelerate epiphyseal maturation more rapidly than linear growth in children, and the effect may continue for 6 months after the drug has been stopped. Therefore, therapy should be monitored by x-ray studied at 6 month intervals in order to avoid the risk of compromising the adult height. The safety and eﬁicacy of Stromba in children with hereditary angioedema have not been established.
In men : Prepubertal: Phallic enlargement and increased frequency of erections.
Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitid and bladder irritability.
In women: Clitoral enlargement. Menstrual irregularties.
In both sexes: increased or decreased libido.
CNS: habituation, excitation, insomnia, depression.
Hematologic: Bleeding in patients on concomitant anticoagulant therapy.
Hair: Hirsutism and male pattern baldness in women.
Skeletal: Premature closure of epiphyses in children use.
Electrolytes: Edema, retention of serum electrolytes.
Metabolic/Endocrine : Decreased glucose tolerance increased serum levels of low-density lipoproteins and decreased levels of high—density lipoproteins increased creatine and creatinine excretion levels of creatinine phosphokinase.
Some virilising changes in women are irreversible even after prompt discontinuance of therapy and are not prevented by concomitant use of estrogens.
Dosage and administration:
Hereditary Angloedems : The dosage requirements for continuous treatment of hereditary angioedema with Stromba should be individualized on the basis of the clinical response of the patient.
Stromba is supplied in 10 x lml ampoule. Ampoules should be stored at controlled room temperatures below 30°C and protected from light. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Warming and shaking the ampoule should redissolve any crystals that may have formed during storage at temperatures lower than recommended. If it has expired or is damaged, return it to your pharmacist for disposal.
Abuse in Sports.
Abuse of this product in sports is highly discouraged. Xwellpharma does not take any responsibility for use of this product for any other purpose. This product should be used iuﬁder proper medical supervision.
Keep out of the reach and sight of children.